4.8 Article

The structure of myostatin: follistatin 288: insights into receptor utilization and heparin binding

期刊

EMBO JOURNAL
卷 28, 期 17, 页码 2662-2676

出版社

WILEY
DOI: 10.1038/emboj.2009.205

关键词

Alk5; follistatin; heparin; myostatin; TGF-beta

资金

  1. NIHGM [R01 GM084186]
  2. AHA [0635097N]
  3. MDA [93887]
  4. Canadian Institutes of Health Research [MOP-89991]
  5. NIDDK, NIH, USA
  6. CIHR

向作者/读者索取更多资源

Myostatin is a member of the transforming growth factor-beta (TGF-beta) family and a strong negative regulator of muscle growth. Here, we present the crystal structure of myostatin in complex with the antagonist follistatin 288 (Fst288). We find that the prehelix region of myostatin very closely resembles that of TGF-beta class members and that this region alone can be swapped into activin A to confer signalling through the non-canonical type I receptor Alk5. Furthermore, the N-terminal domain of Fst288 undergoes conformational rearrangements to bind myostatin and likely acts as a site of specificity for the antagonist. In addition, a unique continuous electropositive surface is created when myostatin binds Fst288, which significantly increases the affinity for heparin. This translates into stronger interactions with the cell surface and enhanced myostatin degradation in the presence of either Fst288 or Fst315. Overall, we have identified several characteristics unique to myostatin that will be paramount to the rational design of myostatin inhibitors that could be used in the treatment of muscle-wasting disorders. The EMBO Journal (2009) 28, 2662-2676. doi: 10.1038/emboj.2009.205; Published online 30 July 2009 Subject Categories: signal transduction; structural biology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据